RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication
Artículo científico (JournalArticle)
Bi-Functional Topospecific Nanoparticles to Promote Immune-Tumor Cell Engagement as A New Immunotherapeutic Strategy
[EN] Cancer immunotherapy has emerged as a promising alternative approach, enabling the body's immune system to fight cancer. Cytotoxic T cells play a pivotal role in recognizing and eliminating tumor cells, and their effectiveness relies on establishing a physical interaction and efficient communication with cancer cells. However, this communication is often disrupted by immune escape mechanisms, allowing cancer progression. A versatile nanoplatform is developed to restore cellular connection using Janus mesoporous silica-Au nanoparticle (J-pHLIP-PD1), including specific binding sites on opposite faces for simultaneous binding to cancer cells and immune cells. The two differential surfaces on the nanoparticle allow orthogonal functionalization with the anti-PD-1 antibody that interacts with the PD-1 receptor in cytotoxic T cells on the gold face and the pH Low Insertion Peptide (pHLIP), which undergoes specific insertion into the tumor cell membrane on the silica face. J-pHLIP-PD1 nanoparticles effectively bind the surface of tumor cells and capture T cells, facilitating the formation of immune synapse-like structures that lead to reduced cancer cell viability in vitro, associated with immunogenic cell death signatures. The therapeutic potential of J-pHLIP-PD1 is also demonstrated in an in vivo metastatic melanoma model, where treatment with J-pHLIP-PD1 produces a significant decrease in metastatic burden and increases T cell presence. The Janus nanosystem represents an attractive platform that expands the toolbox of immune-engaging strategies, offering a flexible alternative to conventional immunotherapies that link immune and tumor cells, restoring cell-cell communication for cancer elimination., A. Ortuno-Bernal, S. Clara-Trujillo and E. Lucena-Sanchez have con-tributed equally to this work. This work was supported by the European Research Council (ERC) via Advanced Grant (101052997, EDI-SON). The authors thank the Spanish Government, project PID2021-126304OB-C41 by MCIN/ AEI /10.13039/501100011033/ and by European Regional Development Fund-A way of doing Europe. This studywas also supported by the Generalitat Valenciana (project PROMETEOCIPROM/2021/007). This study forms part of the Advanced Materials pro-gram (MFA/2022/049) and was supported by MCIN with funding from European Union NextGenerationEU (PRTR-C17.I1) and by Generalitat Valenciana. This work was also supported by CIBER -Consorcio Centro deInvestigacion Biomedica en Red- (CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion. A.G-F. thanks the financial support from FC AECC (IDEAS246782GARC). E.L.-S is grateful for herFPU fellowship funded by MINECO (FPU18/06539). F.J.H thanks MIUfor his FPU grant (FPU20/06021). A.O.B acknowledges support from apredoctoral fellowship funded by the Generalitat Valenciana (GVA, Grant No.CIACIF/2023/320). Samples included in this study were provided bythe Biobanco La Fe (B.0000723) and they were processed following stan-dard operating procedures with the appropriate approval of the Ethics andScientific Committees. Graphical images and schemes were created withBioRender.com.
Project:
Agencia Estatal de Investigación / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2021-126304OB-C41
,
European Commission / HE 101052997
,
Generalitat Valenciana CIPROM/2021/007
,
Generalitat Valenciana CIACIF/2023/320
,
Generalitat Valenciana MFA/2022/049
,
Instituto de Salud Carlos III CB06/01/2012
,
Ministerio de Ciencia FPU20/06021
,
Innovación y Universidades IDEAS246782GARC
,
Asociación Española Contra el Cáncer B.0000723
,
Hospital Universitari i Politècnic La Fe FPU18/06539